Advanced lung adenocarcinoma in an EGFR-positive patient treated with Erlotinib for 52 months

The authors present a case of a 53-years-old non-smoker Caucasian female who was diagnosed with lung adenocarcinoma (stage IA) and underwent surgical resection in 2002. Five years later, the tumor relapsed (stage IV disease) and she initiated chemotherapy with carboplatin, gemcitabine and bevacizuma...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonçalves, Ivone, Ladeira, Inês, Castro, Ana, Antunes, Ana, Barroso, Ana, Parente, Bárbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920415/
https://www.ncbi.nlm.nih.gov/pubmed/26029502
http://dx.doi.org/10.1016/j.rmcr.2013.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920415/
https://www.ncbi.nlm.nih.gov/pubmed/26029502
http://dx.doi.org/10.1016/j.rmcr.2013.06.003

Ejemplares similares